Transcat (NASDAQ:TRNS) Stock Rating Upgraded by StockNews.com

Transcat (NASDAQ:TRNS) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday.

Other equities analysts also recently issued research reports about the stock. HC Wainwright reaffirmed a “buy” rating and set a $156.00 price target on shares of Transcat in a report on Tuesday, October 29th. Craig Hallum upped their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Northland Securities cut their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research note on Wednesday, October 30th. Finally, Oppenheimer reissued an “outperform” rating and set a $130.00 price target (down from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Transcat has an average rating of “Moderate Buy” and a consensus price target of $130.25.

Transcat Stock Performance

Shares of TRNS stock traded down $12.60 during mid-day trading on Tuesday, reaching $86.53. 449,813 shares of the company’s stock traded hands, compared to its average volume of 110,454. The firm has a market capitalization of $796.08 million, a PE ratio of 43.70 and a beta of 0.71. Transcat has a 12 month low of $75.18 and a 12 month high of $147.12. The firm has a 50 day moving average price of $104.98 and a two-hundred day moving average price of $115.11.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.36% and a net margin of 6.63%. During the same quarter last year, the firm earned $0.56 earnings per share. As a group, equities analysts expect that Transcat will post 2.44 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Transcat

Large investors have recently added to or reduced their stakes in the stock. nVerses Capital LLC bought a new stake in shares of Transcat during the third quarter valued at approximately $60,000. US Bancorp DE raised its position in Transcat by 15.6% during the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after purchasing an additional 209 shares in the last quarter. Captrust Financial Advisors purchased a new stake in shares of Transcat in the 3rd quarter worth $201,000. SG Americas Securities LLC bought a new stake in shares of Transcat in the fourth quarter valued at about $182,000. Finally, Walleye Capital LLC bought a new stake in shares of Transcat in the 3rd quarter valued at about $216,000. 98.34% of the stock is owned by hedge funds and other institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.